Long-term outcomes in patients initially responsive to selective laser trabeculoplasty

International Journal of Ophthalmology

Volumn 8, Issue 5, 2015, Pages 960-964

  Patel, Varun ^a   El Hawy, Eman ^a   Waisbourd, Michael ^a   Zangalli, Camila ^a   Shapiro, Daniel M ^a   Gupta, Lalita ^a   Hsieh, Michael ^a   Kasprenski, Abigail ^a   Katz, L Jay ^a   Spaeth, George L ^a  

^a WILLS EYE HOSPITAL   (United States)

Author keywords

Glaucoma; Intraocular pressure; Long term; Maximally tolerated medical therapy; Number of medications used; Selective laser trabeculoplasty

Indexed keywords

EID: 84944583362     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2015.05.19     Document Type: Article

References (25)

1. Latina MA, Tumbocon JA. Selective laser trabeculoplasty: a new treatment option for open angle glaucoma. Curr Opin Ophthalmol 2002;13 (2):94-96
2. Realini T. Selective laser trabeculoplasty: a review. J Glaucoma 2008;17 (6):497-502
3. Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res 1995;60(4): 359-371
4. Stein JD, Challa P. Mechanisms of action and efficacy of argon laser trabeculoplasty and selective laser trabeculoplasty. Curr Opin Ophthalmol 2007;18(2): 140-145
5. Nagar M, Luhishi E, Shah N. Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty. Br J Ophthalmol 2009;93(4):497-501
6. Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, nonrandomized pilot study. Arch Ophthalmol 2003; 121 (7): 957-960
7. Latina MA, Sibayan SA, Shin DH, Noecker RJ, Marcellino G. Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multi-center, pilot, clinical study. Ophthalmol 1998 105(11):2082-2088; discussion 2089-2090
8. Katz LJ, Steinmann WC, Kabir A, Molineaux J, Wizov SS, Marcellino G, SLT/Med Study Group. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial. J Glaucoma 2012;21(7):460-468
9. McIiraith I, Strasfeld M, Colev G, Hutnik CM. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. J Glaucoma 2006;15(2):124-130
10. Juzych MS, Chopra V, Banitt MR, Hughes BA, Kim C, Goulas MT, Shin DH. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology 2004; 111 (10): 1853-1859
11. Weinand FS, Althen F. Long-term clinical results of selective laser trabeculoplasty in the treatment of primary open angle glaucoma. Eur J Ophthalmol 2006;16(1):100-104
12. Gracner T, Falez M, Gracner B, Pahor D. Long-term follow-up of selective laser trabeculoplasty in primary open-angle glaucoma. Klin Monatsbl Augenheilkd 2006;223(9):743-747
13. Lanzetta P, Menchini U, Virgili G. Immediate intraocular pressure response to selective laser trabeculoplasty. Br J Ophthalmol 1999;83(1): 29-32
14. Sayin N, Alkin Z, Ozkaya A, Demir A, Yazici AT, Bozkurt E, Demirok A. Efficacy of selective laser trabeculoplasty in medically uncontrolled glaucoma. ISRN Ophthalmol 2013;2013:975281
15. Koucheki B, Hashemi H. Selective laser trabeculoplasty in the treatment of open-angle glaucoma. J Glaucoma 2012;21(1):65-70
16. Russo V, Barone A, Cosma A, Stella A, Delle Noci N. Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with uncontrolled open-angle glaucoma. Eur J Ophthalmol 2009;19(3):429-434
17. Bovell AM, Damji KF, Hodge WG, Rock WJ, Buhrmann RR, Pan YI. Long term effects on the lowering of intraocular pressure: selective laser or argon laser trabeculoplasty? Can J Ophthalmol 2011;46(5):408-413
18. Sampaolesi R, Sampaolesi JB, Zarate J. Medical Therapy in Glaucoma. The glaucomas: volume 2-open angle glaucoma and angle closure glaucoma New York: Springer;2014:738
19. Bruen R, Lesk MR, Harasymowycz P. Baseline factors predictive of SLT response: a prospective study. J Ophthalmol 2012;2012:642869
20. Ayala M, Chen E. Predictive factors of success in selective laser trabeculoplasty (SLT) treatment. Clin Ophthalmol 2011;5:573-576
21. Rossi GC, Pasinetti GM, Scudeller L, Raimondi M, Lanteri S, Bianchi PE. Risk factors to develop ocular surface disease in treated glaucoma or ocular hypertension patients. Eur J Ophthalmol 2013;23(3):296-302
22. Woo DM, Healey PR, Graham SL, Goldberg I. Intraocular pressure- lowering medications and long-term outcomes of selective laser trabeculoplasty. Clin Experiment Ophthalmol 2014;43(4):320-327
23. Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol 2008;53 Suppl1:S57-68
24. Lee R, Hutnik CM. Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario Health Insurance Plan. Can J Ophthalmol 2006;41(4):449-456
25. Lai JS, Chua JK, Tham CC, Lam DS. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin Experiment Ophthalmol 2004; 32(4):368-372